Holen Sie sich die Stockscreener-App
3.47
1.76%
0.06
Schlusskurs vom Vortag:
$3.41
Offen:
$3.41
24-Stunden-Volumen:
336.42K
Relative Volume:
0.96
Marktkapitalisierung:
$172.22M
Einnahmen:
$230.47M
Nettoeinkommen (Verlust:
$30.28M
KGV:
5.6885
EPS:
0.61
Netto-Cashflow:
$38.86M
1W Leistung:
+0.29%
1M Leistung:
+8.61%
6M Leistung:
+17.63%
1J Leistung:
-6.97%
1-Tages-Spanne:
$3.40
$3.52
1-Wochen-Bereich:
$3.335
$3.545
52-Wochen-Spanne:
$2.225
$4.13
Puma Biotechnology Inc Stock (PBYI) Company Profile
Firmenname
Puma Biotechnology Inc
Sektor
Branche
Telefon
(424) 248-6500
Adresse
10880 WILSHIRE BLVD., LOS ANGELES, CA
Vergleichen Sie PBYI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
3.47 | 171.75M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-10-08 | Herabstufung | Goldman | Neutral → Sell |
| 2019-05-10 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-01-17 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2019-01-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2018-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-11-02 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Eingeleitet | Goldman | Sell |
| 2018-05-11 | Bestätigt | Stifel | Buy |
| 2017-11-10 | Bestätigt | Citigroup | Buy |
| 2017-11-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Bestätigt | Stifel | Buy |
| 2017-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2017-07-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-06-06 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Puma Biotechnology Inc. Stock Analysis and ForecastTriple-digit profit margins - jammulinksnews.com
What drives Puma Biotechnology Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
Cesano sells Puma biotechnology shares worth $90,909 By Investing.com - Investing.com Canada
What analysts say about Puma Biotechnology Inc. stockPowerful market insights - jammulinksnews.com
Does Puma Biotechnology Inc. stock pay reliable dividendsFree Stock Market Insider Analysis - Newser
Is Puma Biotechnology Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
how puma biotechnology inc. stock performs during market volatilityFree Stock Selection - Newser
How Puma Biotechnology Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Why Puma Biotechnology Inc. stock attracts strong analyst attentionStrong Buy Recommendations - Newser
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? - NewsBreak: Local News & Alerts
What makes Puma Biotechnology Inc. stock price move sharplySafer Investing With Bigger Upside - Newser
Puma biotechnology CFO Nougues sells $33649 in stock By Investing.com - Investing.com South Africa
Puma biotechnology CFO Nougues sells $33649 in stock - Investing.com India
Puma biotechnology SVP Hunt sells $27624 in stock By Investing.com - Investing.com South Africa
Puma biotechnology SVP Hunt sells $27624 in stock - Investing.com Australia
Puma Biotechnology Executives Sell Shares Amid Ongoing Company Challenges - AInvest
Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors - Yahoo Finance
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Puma Biotechnology, Inc.(NasdaqGS: PBYI) dropped from Russell 2000 Growth Index - MarketScreener
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Yahoo Finance
Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment (NASDAQ:PBYI) - Seeking Alpha
Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain - Nasdaq
Puma Biotechnology Updates Bylaws for Compliance - TipRanks
Puma Biotechnology Holds Annual Stockholders Meeting 2025 - TipRanks
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance
With 57% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) boasts of strong institutional backing - Yahoo Finance
Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):